Our Curious Amalgam

Toggle navigation
  • About
  • Hosts
  • Gallery
  • Episodes
  • ABA
  • Search

Category: INDUSTRIES

Mika Ikeda, Senior Counsel, Competition Law, Johnson & Johnson

#257 Throwing the Book at Orange Book Listings? The FTC’s Views on the Antitrust Implications of Listing Patents in the Orange Book

Posted 3 years ago Tagged FDA generic drugs Orange Book patents Section 5

The interplay between patent law and competition law has been a consistent focus for the […]

https://ourcuriousamalgam.com/episode-player/2930/257-orange-book-patent-listings.mp3?stats-code=ocaPodcastSite
Josh Grant

#253 Ready, Player One? Antitrust and Online Gaming

Posted 3 years ago Tagged online gaming video games

The online gaming industry has been the subject of legal challenges in the antitrust and […]

https://ourcuriousamalgam.com/episode-player/2895/253-online-gaming.mp3?stats-code=ocaPodcastSite
Dr. Russell Pittman, Director of Economic Research, Antitrust Division of the U.S. Department of Justice

#247 Has the System Derailed? The State of Competition in the US Freight Rail Sector

Posted 3 years ago Tagged antitrust competition freight litigation merger railroad regulation

Some have expressed concerns over a lack of competition in the U.S. rail freight and […]

https://ourcuriousamalgam.com/episode-player/2859/247-us-freight-rail.mp3?stats-code=ocaPodcastSite
Casey Mulligan, Professor of Economics, University of Chicago

#241 Are PBMs Good For Competition? A Cost-Benefit Analysis of the Effects of Regulating Pharmacy Benefit Managers

Posted 3 years ago Tagged drug prices health care PBMs pharmacy benefit managers

Pharmacy benefit managers (PBMs) are being called out for engaging in allegedly anticompetitive business practices […]

https://ourcuriousamalgam.com/episode-player/2820/241-pharmacy-benefit-managers.mp3?stats-code=ocaPodcastSite
Theodosia Stavroulaki, Assistant Professor of Law, Gonzaga University School of Law

#240 Can Competition and Quality Coincide? Analyzing a Systematic Competition Law Approach to Healthcare and Quality Concerns

Posted 3 years ago Tagged health equity healthcare mergers quality of care

The role of antitrust in health care is a common topic in the antitrust world. […]

https://ourcuriousamalgam.com/episode-player/2816/240-healthcare-quality-competition.mp3?stats-code=ocaPodcastSite
Damian Didden, Partner, Wachtell, Lipton, Rosen & Katz

#237 Should We Bank on Changes? A Conversation About Bank Merger Policy

Posted 3 years ago Tagged banking merger guidelines

Bank failures in 2023 led to renewed interest in bank consolidation and debate over the […]

https://ourcuriousamalgam.com/episode-player/2800/237-bank-merger-policy.mp3?stats-code=ocaPodcastSite
Nicholas Lawson, General Counsel, Argyle Systems Inc.

#234 What About Small Tech? Democratizing Employment Data

Posted 3 years ago Tagged employment data financial data rights financial services open banking open payroll payroll data

Employment data is a critical component of the financial ecosystem—it’s required documentation if you want […]

https://ourcuriousamalgam.com/episode-player/2776/234-small-tech-employment-data.mp3?stats-code=ocaPodcastSite
Doug Kantor, General Counsel, National Association of Convenience Stores

#230 Will That Be Cash or Credit? Swipe Fees and Their Critics

Posted 3 years ago Tagged charge cards credit cards debit cards interchange fees payment systems swipe fees

The credit card industry has been the subject of increased antitrust scrutiny in recent years, […]

https://ourcuriousamalgam.com/episode-player/2750/230-swipe-fees.mp3?stats-code=ocaPodcastSite
LIV and Let Live? The Antitrust Fight Between the PGA and LIV Golf.

#218 LIV and Let Live? The Antitrust Fight Between the PGA and LIV Golf.

Posted 3 years ago Tagged antitrust conflicting events golf Greg Norman LIV media rights monopolization PGA professional golf Saudi Arabia

LIV Golf is the most serious threat the PGA has ever faced, and the fight […]

https://ourcuriousamalgam.com/episode-player/2666/218-liv-pga.mp3?stats-code=ocaPodcastSite
Dr. Erin Trish, Co-Director, Schaeffer Center for Health Policy & Economics, University of Southern California

#212 A Sickness or a Cure for High Drug Prices? Why PBMs Are Under the Antitrust Microscope

Posted 4 years ago Tagged drug prices FTC insulin PBMs pharmacies pharmacy benefit managers

Drug prices are top of mind for numerous patients, legislators, policy experts, and antitrust enforcers […]

https://ourcuriousamalgam.com/episode-player/2622/212-high-drug-prices-pbm.mp3?stats-code=ocaPodcastSite
Previous Page 1 Page 2 Page 3 … Page 5 Next
Subscribe
Listen on Apple Podcasts
Spotify
Amazon music
Audible
YouTube Music
Browse by category
Scroll to the top

Don't miss new episodes every Monday. Subscribe now!

Our Curious Amalgam explores topics in antitrust, competition, consumer protection, data protection, and privacy law around the world with leading experts in those areas. It is an amalgam because it is a group of diverse topics all in one place. It is curious because it gets the experts and asks them in-depth questions.

© 2019-2026 American Bar Association. All Rights Reserved.

NEWS AND EVENTS
What's Going on at the Antitrust Law Section

CONTACT US
podcast@ourcuriousamalgam.com

Find us on social!

Facebook Twitter Instagram LinkedIn RSS Feed

Subscribe
Listen on Apple Podcasts
Listen on Spotify
Amazon music
Audible
YouTube Music
The opinions expressed by the participants in the podcasts are their own and do not necessarily represent those of their employers or other affiliated organizations.